Guggenheim Capital LLC Inovio Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $794,827 - $1.19 Million	-159,284 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $43,403 - $58,740	6,062 Added 3.96%	159,284 $1.14 Million
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $32,844 - $52,878	5,272 Added 3.56%	153,222 $1.42 Million
Q1 2021 May 13, 2021	SELL	$8.81 - $16.96 $54,296 - $104,524	-6,163 Reduced 4.0%	147,950 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $186,711 - $282,263	21,966 Added 16.62%	154,113 $1.36 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $1.26 Million - $3.57 Million	132,147 New	132,147 $1.53 Million
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $1.32 Million - $2.37 Million	-578,013 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $1,265 - $1,932	379 Added 0.07%	578,013 $2.16 Million
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $283,254 - $444,905	72,816 Added 14.42%	577,634 $2.31 Million
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $1,536 - $2,187	392 Added 0.08%	504,818 $2.81 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $1,098 - $1,460	-283 Reduced 0.06%	504,426 $1.98 Million
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $2.04 Million - $2.87 Million	504,709 New	504,709 $2.38 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $546M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.